"The 'tongue in cheek' writing style seems a bit childish... If you had have just stopped after your first line, you would have made a decent point based on facts. Instead you waffle on about nonsense for a number of paragraphs afterwards and lose much of your credibility."
@TeaBone,
I'm sorry my writing style is not to your liking.
I'll pose the question to you in more clinical terms:
After how many years have passed, with no update (other than "We are still in discussion"), do you think it can be deemed that discussions between Mesoblast and Celgene are inconclusive?
Celgene @ 18 months, page-3
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5460 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 978 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |